Venus Concept Inc. (VERO) Q1 2023 Earnings Call Transcript
- Venus Concept Inc. (NASDAQ:VERO ) Q1 2023 Earnings Conference Call May 15, 2023 8:00 AM ET Company Participants Rajiv De Silva - CEO Hemanth Varghese - President & Chief Innovation and Business Officer Domenic Della Penna - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
- 05/15/2023
|
Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023
- TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.
- 04/11/2023
|
Venus Concept Inc. (VERO) Q4 2022 Earnings Call Transcript
- Venus Concept Inc. (NASDAQ:VERO ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Innovation and Business Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
- 03/27/2023
|
Trading Penny Stocks? Top Technical Analysis Tips
- Can this help you to make money with penny stocks? The post Trading Penny Stocks?
- 12/22/2022
|
Why Is Venus Concept (VERO) Stock Up 81% Today?
- Venus Concept (NASDAQ: VERO ) stock is rocketing higher on Wednesday following approval for its fractional skin resurfacing technology. The U.S. Food and Drug Administration (FDA) has signed off on the company's surgical robotic technology platform called AI.ME.
- 12/21/2022
|
Why Venus Concept (VERO) Shares Are Trading Higher Premarket Today? - Venus Concept (NASDAQ:VERO)
- � 2022 Benzinga.com. Benzinga does not provide investment advice.
- 12/21/2022
|
Best Penny Stocks To Buy Now? 7 Insider Picks In November
- 7 penny stock picks from insiders in November 2022 The post Best Penny Stocks To Buy Now? 7 Insider Picks In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 11/25/2022
|
Best Penny Stocks To Buy Now? 4 Insider Picks In November
- Penny stock picks from insiders in November 2022. The post Best Penny Stocks To Buy Now?
- 11/23/2022
|
Activist Masters Capital Double Position in Venus Concept (VERO)
- Fintel reports that Masters Capital Management Llc has filed a 13D/A form with the SEC disclosing ownership of 22,999,173 shares of Venus Concept Inc (VERO).
- 11/23/2022
|
Venus Concept Inc. (VERO) Q3 2022 Earnings Call Transcript
- Venus Concept Inc. (NASDAQ:VERO ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Corporate Participants Rajiv De Silva - Chief Executive Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Marie Thibault - BTIG Anthony Vendetti - Maxim Group Operator Good day, ladies and gentlemen and welcome to the Third Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
- 11/10/2022
|
How to Make Money With Penny Stocks in a Volatile Market
- Which strategies are you using to trade penny stocks right now? The post How to Make Money With Penny Stocks in a Volatile Market appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 09/03/2022
|
Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2022 Results - Earnings Call Transcript
- Venus Concept Inc. (NASDAQ:VERO ) Q2 2022 Earnings Conference Call August 12, 2022 4:30 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Marie Thibault - BTIG John Block - Stifel Anthony Vendetti - the Maxim Group Operator Good day, ladies and gentlemen. And welcome to the Second Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode.
- 08/12/2022
|
Venus Concept (VERO) Reports Q2 Loss, Misses Revenue Estimates
- Venus Concept (VERO) delivered earnings and revenue surprises of -100% and 9.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/12/2022
|
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022
- TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2022 financial results will be released before the market opens on Friday, August 12, 2022.
- 06/30/2022
|
Venus Concept Inc. (VERO) CEO Dom Serafino on Q1 2022 Results - Earnings Call Transcript
- Venus Concept Inc. (NASDAQ:VERO ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Conference Call Participants Marie Thibault - BTIG Jeffrey Cohen - Ladenburg Thalmann Jon Block - Stifel Anthony Vendetti - Maxim Group Operator Please standby. Good day, ladies and gentlemen and welcome to the First Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed on a listen-only mode.
- 05/12/2022
|
Venus Concept (VERO) Reports Q1 Loss, Misses Revenue Estimates
- Venus Concept (VERO) delivered earnings and revenue surprises of -30% and 2.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/12/2022
|
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
- TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2022 financial results will be released after the market closes on Thursday, May 12, 2022.
- 04/04/2022
|
Venus Concept Inc. (VERO) CEO Dom Serafino on Q4 2021 Results - Earnings Call Transcript
- Venus Concept Inc. (VERO) CEO Dom Serafino on Q4 2021 Results - Earnings Call Transcript
- 03/28/2022
|
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates
- Venus Concept (VERO) delivered earnings and revenue surprises of 33.33% and 0.41%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/28/2022
|
Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th
- TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will present at the Maxim Virtual Growth Conference, which is being held virtually from March 28th-30th.
- 03/21/2022
|
Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022
- TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March 28, 2022.
- 02/02/2022
|
Penny Stocks To Buy Now According To Insiders In December 2021
- Insiders are buying these penny stocks during "tax loss season" The post Penny Stocks To Buy Now According To Insiders In December 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 12/20/2021
|
Venus Concept Inc. (VERO) CEO Dom Serafino on Q3 2021 Results - Earnings Call Transcript
- Venus Concept Inc. (VERO) CEO Dom Serafino on Q3 2021 Results - Earnings Call Transcript
- 11/12/2021
|
Venus Concept Stock Down As Q3 Earnings Trail Street Expectations
- Venus Concept Inc's (NASDAQ: VERO) Q3 sales increased 19% Y/Y to $24.6 million, missing the consensus of $26.43 million. On a sequential basis, the sales declined around 5%.
- 11/12/2021
|
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 11/05/2021
|
Venus Concept's Pain Management Device Scores FDA Nod
- The FDA has given 510(k) clearance to Venus Concept Inc's (NASDAQ: VERO) Venus Freedom device for pain management. Venus Freedom is a noninvasive, non-ablative device with three applicators to deliver non-thermal radiofrequency energy combined with massage and magnetic field pulses.
- 10/19/2021
|
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
- TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus Freedom device in the United States.
- 10/19/2021
|
Venus Concept Appoints Ross J. Portaro as President of Global Sales
- TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Ross J. Portaro to the position of President of Global Sales, effective October 15, 2021. Mr. Portaro will assume the responsibilities of Chad A. Zaring, who is resigning from his role of Chief Commercial Officer for personal reasons, effective October 15, 2021. Mr. Zaring will continue to support the Company as a consultant through March 31, 2022.
- 10/12/2021
|
Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021
- TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2021 financial results will be released before the market opens on Friday, November 12, 2021.
- 10/04/2021
|
Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
- TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13th-15th. Management's presentation will be available on-demand beginning on Monday, September 13th at 7:00 a.m. Eastern Time. Management will participate in virtual investor meetings on Tuesday, September 14th throughout the day.
- 09/07/2021
|
Forget Bargains, Play 5 Stocks with Rising P/E Instead
- Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
- 09/02/2021
|
Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2021 Results - Earnings Call Transcript
- Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2021 Results - Earnings Call Transcript
- 08/13/2021
|
Venus Concept Stock Trades Higher After Lifting FY21 Sales Outlook
- Venus Concept Inc's (NASDAQ: VERO) Q2 sales increased 52% Y/Y to $25.8 million, beating the consensus of $24.26 million. The increase by product category was driven by a 71% increase in lease revenue, a 29% increase in systems revenue, an 86% increase in products revenue, and a 5% increase in services revenue.
- 08/13/2021
|
Venus Concept (VERO) Reports Q2 Loss, Tops Revenue Estimates
- Venus Concept (VERO) delivered earnings and revenue surprises of 71.43% and 6.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/13/2021
|
Venus Concept Shares Increase Over 15% Pre-Market: Why It Happened
- The shares of Venus Concept Inc. (NASDAQ: VERO) increased by over 15% pre-market. This is why it happened.
- 08/13/2021
|
Recap: Venus Concept Q2 Earnings
- Shares of Venus Concept (NASDAQ:VERO) rose 15.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 102.56% year over year to $0.01, which beat the estimate of ($0.12).
- 08/13/2021
|
Venus Concept Announces Second Quarter 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
- TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2021.
- 08/13/2021
|
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should Know
- Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/06/2021
|
Venus Concept: Pandemic And Debt Obscure Promise Of Medical Aesthetics Business
- Venus is a supplier of medical aesthetics products on a buy or lease basis that merged with Restoration Hair Robotics in November 2019. Nearly 2 years on however, Venus' enlarged business is yet to hit its stride, burdened by debt and pandemic headwinds.
- 07/31/2021
|
Venus Concept Announces Health Canada Authorization and CE Mark for Venus Fiore® Feminine Health System
- TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Fiore Feminine Health System in Canada. This follows the receipt of CE Mark for the Venus Fiore Feminine Health System in March 2020. The Company intends to begin a limited launch of the Venus Fiore in Canada and the European Union in the third quarter of 2021.
- 07/20/2021
|
Venus Concept Inc. to Participate in the Ladenburg Thalmann Healthcare Conference on July 13th
- TORONTO, July 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Ladenburg Thalmann Healthcare Conference.
- 07/12/2021
|
Venus Concept to Release Second Quarter of Fiscal Year 2021 Financial Results on August 13, 2021
- TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2021 financial results will be released before the market opens on Friday, August 13, 2021.
- 07/08/2021
|
VERO Stock Price Increases Over 9% Pre-Market: Why It Happened
- The stock price of Venus Concept Inc (NASDAQ: VERO) increased by over 9% pre-market. This is why it happened.
- 06/16/2021
|
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q1 2021 Results - Earnings Call Transcript
- Venus Concept Inc. (VERO) CEO Domenic Serafino on Q1 2021 Results - Earnings Call Transcript
- 05/18/2021
|
Venus Concept Announces First Quarter of 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
- TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2021.
- 05/17/2021
|
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should Know
- Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/10/2021
|
Moving Average Crossover Alert: Venus Concept (VERO)
- Venus Concept (VERO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
- 04/28/2021
|
Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
- TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17, 2021.
- 04/08/2021
|
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q4 2020 Results - Earnings Call Transcript
- Venus Concept Inc. (VERO) CEO Domenic Serafino on Q4 2020 Results - Earnings Call Transcript
- 03/29/2021
|
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates
- Venus Concept (VERO) delivered earnings and revenue surprises of -37.50% and 0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 03/29/2021
|
Venus Concept: Q4 Earnings Insights
- Shares of Venus Concept (NASDAQ:VERO) increased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 74.77% over the past year to ($0.27), which missed the estimate of ($0.19).
- 03/29/2021
|
Venus Concept Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Reaffirms Fiscal Year 2021 Revenue Guidance
- TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2020.
- 03/29/2021
|
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 03/22/2021
|
Venus Concept Inc. to Present at the H.C. Wainwright Annual Global LifeSciences Conference on March 9th
- TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will attend and present at the H.C. Wainwright Annual Global LifeSciences Conference, which is being held virtually from March 9th-10th. Management's presentation will be available on-demand beginning on Tuesday, March 9th at 7:00 a.m. Eastern Time.
- 03/04/2021
|
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th
- TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
- 02/09/2021
|
Venus Concept to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 29, 2021
- TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Monday, March 29, 2021.
- 02/08/2021
|
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance
- TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2020 and introduced revenue guidance expectations for the twelve months ended December 31, 2021.
- 01/14/2021
|
Venus Concept Inc. to Present at Two Upcoming Investor Conferences in January
- TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in January:
- 01/05/2021
|
Venus Concept Inc. Announces Pricing of $22.5 Million Public Offering
- TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of its public offering of 11,250,000 shares of its common stock and warrants to purchase 5,625,000 shares of common stock at a combined offering price to the public of $2.00 per share and accompanying warrant. The warrants have an exercise price of $2.50 per share of common stock, are exercisable immediately, and expire five years from the date of issuance. Venus Concept intends to use the gross proceeds of approximately $22.5 million, before deducting underwriting discounts and commissions and estimated offering expenses, from the offering for general corporate purposes, including the funding of research and development activities.
- 12/22/2020
|
Venus Concept Inc. Announces Proposed Public Offering
- TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement. All of the common stock and warrants to be sold in the proposed offering are to be sold by Venus Concept. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- 12/21/2020
|
Venus Concept Announces Debt Refinancing
- New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future cash flow New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future cash flow
- 12/10/2020
|
Venus Concept to Host Virtual “Aesthetic & Hair Restoration Technology” Event on December 10th
- TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company will host a virtual “ Aesthetic & Hair Restoration Technology ” event on Thursday, December 10, 2020. The live webcast of the event will begin at 10:00 a.m. ET and conclude at approximately 12:00 p.m. ET.
- 12/01/2020
|
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript
- Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript
- 11/16/2020
|
Venus Concept Announces Third Quarter and First Nine Months of 2020 Financial Results
- TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2020.
- 11/16/2020
|
Venus Concept Inc. to Present at the Stifel 2020 Virtual Healthcare Conference
- TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2020 Virtual Healthcare Conference. Management will present on Monday, November 16th at 4:00 p.m. Eastern Time.
- 11/03/2020
|
